Moran Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
Moran Wealth Management's SBIO Position: Q3 2026 in Review
Moran Wealth Management increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 6.1% in Q3 2026, buying an estimated $136K and bringing the position to 36,110 shares worth $2.11M. The position accounts for 0.06% of the portfolio, ranked #315.
Moran Wealth Management first reported a position in SBIO in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.2M in Q2 2026. 77 funds tracked by Wall St. Rank hold SBIO as of Q3 2026.
- Moran Wealth Management held 36,110 shares of ALPS Medical Breakthroughs ETF worth $2.11M as of Q3 2026.
- Moran Wealth Management bought 2,080 ALPS Medical Breakthroughs ETF shares in Q3 2026, an estimated $136K.
- ALPS Medical Breakthroughs ETF made up 0.06% of Moran Wealth Management's portfolio in Q3 2026, its #315 holding.
- Moran Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q2 2025 and has held it in 6 quarters since.
- Moran Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $2.2M in Q2 2026.
- 77 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2026.
Based on Moran Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.